ClinicalTrials.gg
Drug

Liposomal Docetaxel clinical trials

A product of Docetaxel; its studies count on that page too.

studies test it
3
open now
0
in phase 3
0
first study started
2008

How each study uses Liposomal Docetaxel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
14 May 1996 · TAXOTERE · NDA 020449 (FDA, Drugs@FDA; as Docetaxel)
European Union
27 Nov 1995 · Taxotere · EMEA/H/C/000073 (EMA; as Docetaxel)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

LE-DT
3
Liposome Entrapped Docetaxel (LE-DT)
2
Liposomal Docetaxel
2

Studies by the year they started

3 studies that test it; most in 2010 (2)

Studies that test Liposomal Docetaxel, by start year
YearStudies
20081
20102

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 3 · Other 0

INSYS Therapeutics Inc (3)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Liposomal Docetaxel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 3